Benzinga's Top #PreMarket Gainers
November 27, 2013 at 08:24 AM EST
GW Pharmaceuticals plc (NASDAQ: GWPH ) surged 10% to $38.50 in the pre-market session after the company received regulatory approval for Sativex in Switzerland. Crocs (NASDAQ: CROX ) shares gained 7.09% to $14.50 in the pre-market following a Bloomberg story suggesting the company is in talks with firms for
